What is REVB's current stock price?

REVB (Revelation Biosciences, Inc.) is currently trading at $1.07 with a market cap of $4.2M.

What sector is Revelation Biosciences, Inc. in?

Revelation Biosciences, Inc. (REVB) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

REVB Revelation Biosciences, Inc.

Healthcare

$1.07-0.93%ClosedMarket Cap: $4.2M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.26

P/S

0.00

EV/EBITDA

0.91

DCF Value

$15.15

FCF Yield

-209.5%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-107.7%

ROA

-65.6%

ROIC

-73.2%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$0.00	$-3.0M	$—
Q4 null	$0.00	$-2.5M	$—
FY null	$0.00	$-8.9M	$—
Q3 null	$0.00	$-1.9M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All

Zygmont Chester Stanley IIIofficer: Chief Financial Officer

SellFri May 01

Rolke Jamesdirector, officer: Chief Executive Officer

SellFri May 01

Zygmont Chester Stanley IIIofficer: Chief Financial Officer

SellThu Feb 05

ROPER JESSdirector

SellThu Feb 05

Rolke Jamesdirector, officer: Chief Executive Officer

SellThu Feb 05

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

-0.14

Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California.

Peers

PBM